|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 179.35 SEK | -1.21% |
|
+0.42% | -3.52% |
| 01-15 | Kepler Cheuvreux Raises Target Price for H&M to 200 Kronor (190), Reiterates Buy - BN | FW |
| 01-14 | SHB Reiterates Buy Rating for H&M Ahead of Report – Market Underestimates Margin | FW |
| Fiscal Period: November | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 1.31 | 5.38 | 2.48 | 4.67 | 6.01 | |||||
Return on Total Capital | 1.85 | 7.29 | 3.58 | 6.81 | 8.74 | |||||
Return On Equity % | 2.23 | 19.21 | 6.44 | 17.74 | 24.72 | |||||
Return on Common Equity | 2.23 | 19.21 | 6.44 | 17.81 | 24.84 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 50.02 | 52.78 | 50.67 | 51.22 | 53.44 | |||||
SG&A Margin | 48.36 | 45.11 | 47.46 | 45.47 | 46.02 | |||||
EBITDA Margin % | 7.43 | 12.1 | 7.27 | 8.81 | 10.17 | |||||
EBITA Margin % | 1.72 | 7.73 | 3.26 | 5.81 | 7.47 | |||||
EBIT Margin % | 1.66 | 7.67 | 3.21 | 5.75 | 7.41 | |||||
Income From Continuing Operations Margin % | 0.66 | 5.53 | 1.6 | 3.7 | 4.94 | |||||
Net Income Margin % | 0.66 | 5.53 | 1.6 | 3.71 | 4.96 | |||||
Net Avail. For Common Margin % | 0.66 | 5.53 | 1.6 | 3.71 | 4.96 | |||||
Normalized Net Income Margin | 0.69 | 4.49 | 1.74 | 3.46 | 4.13 | |||||
Levered Free Cash Flow Margin | 9.31 | 19.57 | 8.86 | 9.35 | 7 | |||||
Unlevered Free Cash Flow Margin | 9.75 | 19.93 | 9.17 | 9.92 | 7.74 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.27 | 1.12 | 1.24 | 1.3 | 1.3 | |||||
Fixed Assets Turnover | 2.83 | 2.33 | 2.75 | 2.87 | 2.8 | |||||
Receivables Turnover (Average Receivables) | 41.72 | 64.76 | 73.62 | 74.75 | 52.5 | |||||
Inventory Turnover (Average Inventory) | 2.46 | 2.49 | 2.76 | 2.88 | 2.81 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.16 | 1.29 | 1.16 | 1.19 | 1.14 | |||||
Quick Ratio | 0.41 | 0.58 | 0.47 | 0.55 | 0.45 | |||||
Operating Cash Flow to Current Liabilities | 0.46 | 0.73 | 0.36 | 0.5 | 0.48 | |||||
Days Sales Outstanding (Average Receivables) | 8.77 | 5.64 | 4.96 | 4.88 | 6.97 | |||||
Days Outstanding Inventory (Average Inventory) | 148.83 | 146.67 | 132.07 | 126.57 | 130.25 | |||||
Average Days Payable Outstanding | 33.82 | 58.62 | 65.55 | 69.87 | 74.14 | |||||
Cash Conversion Cycle (Average Days) | 123.78 | 93.68 | 71.47 | 61.58 | 63.08 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 146.58 | 111.12 | 143.1 | 163.8 | 166.53 | |||||
Total Debt / Total Capital | 59.44 | 52.63 | 58.87 | 62.09 | 62.48 | |||||
LT Debt/Equity | 107.81 | 90.9 | 116.09 | 131.96 | 139.53 | |||||
Long-Term Debt / Total Capital | 43.72 | 43.06 | 47.75 | 50.02 | 52.35 | |||||
Total Liabilities / Total Assets | 68.67 | 66.62 | 72.12 | 73.74 | 74.36 | |||||
EBIT / Interest Expense | 2.39 | 13.17 | 6.43 | 6.33 | 6.31 | |||||
EBITDA / Interest Expense | 21.43 | 31.2 | 25.19 | 15.71 | 13.39 | |||||
(EBITDA - Capex) / Interest Expense | 18.65 | 28.84 | 21.13 | 11.98 | 9.74 | |||||
Total Debt / EBITDA | 2.88 | 1.85 | 2.59 | 2.32 | 2.09 | |||||
Net Debt / EBITDA | 2.28 | 1.09 | 1.81 | 1.53 | 1.62 | |||||
Total Debt / (EBITDA - Capex) | 3.3 | 2 | 3.08 | 3.04 | 2.87 | |||||
Net Debt / (EBITDA - Capex) | 2.62 | 1.17 | 2.16 | 2.01 | 2.22 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -19.64 | 6.38 | 12.36 | 5.58 | -0.66 | |||||
Gross Profit, 1 Yr. Growth % | -23.61 | 12.25 | 7.88 | 6.64 | 3.64 | |||||
EBITDA, 1 Yr. Growth % | -49.34 | 73.31 | -32.54 | 38.08 | 14.74 | |||||
EBITA, 1 Yr. Growth % | -81.59 | 377.09 | -52.65 | 81.65 | 27.76 | |||||
EBIT, 1 Yr. Growth % | -82.13 | 392.26 | -53.01 | 82.39 | 28.14 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -90.75 | 785.76 | -67.61 | 144.62 | 32.9 | |||||
Net Income, 1 Yr. Growth % | -90.75 | 785.76 | -67.61 | 145.43 | 32.89 | |||||
Normalized Net Income, 1 Yr. Growth % | -88.2 | 596.88 | -56.53 | 110.04 | 18.73 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -90.75 | 785.76 | -67.51 | 148.56 | 34.32 | |||||
Accounts Receivable, 1 Yr. Growth % | -47.51 | -0.88 | -1.47 | 9.52 | 70.58 | |||||
Inventory, 1 Yr. Growth % | 1.02 | -2.36 | 13.91 | -12.09 | 8 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 122.96 | -12.63 | 3.86 | -1.45 | 5.74 | |||||
Total Assets, 1 Yr. Growth % | 44.72 | 3.1 | 1.26 | -0.43 | -0.58 | |||||
Tangible Book Value, 1 Yr. Growth % | -3.93 | 9.86 | -15.4 | -9.44 | -2.55 | |||||
Common Equity, 1 Yr. Growth % | -4.29 | 9.88 | -15.43 | -6.38 | -2.71 | |||||
Cash From Operations, 1 Yr. Growth % | -10.65 | 72.27 | -45.14 | 37.2 | -6.46 | |||||
Capital Expenditures, 1 Yr. Growth % | -51.16 | -24.38 | 66.01 | 76.41 | 25.97 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 1.1 | 123.53 | -48.87 | 19.13 | -25.59 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 4.56 | 117.54 | -48.04 | 21.78 | -22.5 | |||||
Dividend Per Share, 1 Yr. Growth % | - | - | 0 | 0 | 4.62 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -5.72 | -7.54 | 9.33 | 8.92 | 2.41 | |||||
Gross Profit, 2 Yr. CAGR % | -8.15 | -7.4 | 10.04 | 7.3 | 5.13 | |||||
EBITDA, 2 Yr. CAGR % | -24.94 | -6.29 | 8.13 | -7.1 | 25.87 | |||||
EBITA, 2 Yr. CAGR % | -54.63 | -6.29 | 50.3 | -5.56 | 52.34 | |||||
EBIT, 2 Yr. CAGR % | -55.28 | -6.22 | 52.1 | -5.7 | 52.88 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -68.66 | -9.5 | 69.38 | -10.99 | 80.23 | |||||
Net Income, 2 Yr. CAGR % | -68.66 | -9.5 | 69.38 | -10.84 | 80.52 | |||||
Normalized Net Income, 2 Yr. CAGR % | -63.78 | -9.32 | 74.05 | -4.45 | 57.92 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -68.66 | -9.5 | 69.65 | -10.13 | 82.65 | |||||
Accounts Receivable, 2 Yr. CAGR % | -30.17 | -27.87 | -1.17 | 3.88 | 36.69 | |||||
Inventory, 2 Yr. CAGR % | 0.64 | -0.69 | 5.46 | 0.07 | -2.56 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 46.57 | 39.57 | -4.74 | 1.17 | 2.08 | |||||
Total Assets, 2 Yr. CAGR % | 21.16 | 22.15 | 2.18 | 0.41 | -0.5 | |||||
Tangible Book Value, 2 Yr. CAGR % | -3.16 | 2.73 | -3.59 | -12.47 | -6.15 | |||||
Common Equity, 2 Yr. CAGR % | -3.41 | 2.55 | -3.6 | -11.02 | -4.65 | |||||
Cash From Operations, 2 Yr. CAGR % | 10.3 | 24.07 | -2.79 | -12.77 | 13.28 | |||||
Capital Expenditures, 2 Yr. CAGR % | -38.57 | -39.23 | 12.04 | 71.13 | 49.07 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 63.01 | 50.33 | 6.66 | -24.54 | -5.85 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 65.62 | 50.82 | 6.07 | -23 | -2.85 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | - | - | 0 | 2.28 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -2.21 | -1.85 | -1.34 | 8.07 | 5.63 | |||||
Gross Profit, 3 Yr. CAGR % | -4.7 | -1.8 | -2.56 | 8.93 | 6.07 | |||||
EBITDA, 3 Yr. CAGR % | -21.56 | -0.79 | -16.02 | 14.37 | -0.32 | |||||
EBITA, 3 Yr. CAGR % | -46.27 | -0.6 | -25.36 | 62.05 | 4.45 | |||||
EBIT, 3 Yr. CAGR % | -46.79 | -0.51 | -25.51 | 63.58 | 4.45 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -57.49 | -4.53 | -35.75 | 91.45 | 1.71 | |||||
Net Income, 3 Yr. CAGR % | -57.49 | -4.53 | -35.75 | 91.67 | 1.82 | |||||
Normalized Net Income, 3 Yr. CAGR % | -53.8 | -2.94 | -29.03 | 85.3 | 2.73 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -57.49 | -4.53 | -35.68 | 92.68 | 2.72 | |||||
Accounts Receivable, 3 Yr. CAGR % | -16.48 | -21.52 | -19.96 | 2.27 | 22.56 | |||||
Inventory, 3 Yr. CAGR % | 4.26 | -0.37 | 3.96 | -0.75 | 2.65 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 31.8 | 23.36 | 26.48 | -3.66 | 2.67 | |||||
Total Assets, 3 Yr. CAGR % | 17.84 | 14.81 | 14.75 | 1.3 | 0.08 | |||||
Tangible Book Value, 3 Yr. CAGR % | -2.71 | 1 | -3.71 | -5.58 | -9.34 | |||||
Common Equity, 3 Yr. CAGR % | -2.93 | 0.83 | -3.83 | -4.54 | -8.39 | |||||
Cash From Operations, 3 Yr. CAGR % | 6.26 | 27.98 | -5.48 | 9.44 | -10.72 | |||||
Capital Expenditures, 3 Yr. CAGR % | -29.55 | -34.17 | -15.05 | 30.35 | 54.52 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 48.57 | 81.1 | 4.77 | 8.21 | -24.89 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 50.6 | 81.38 | 5.57 | 8.69 | -22.83 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | -12.64 | - | - | 1.52 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 0.67 | 0.69 | 2.25 | 2.33 | 0.15 | |||||
Gross Profit, 5 Yr. CAGR % | -1.94 | -0.22 | 0.94 | 1.74 | 0.46 | |||||
EBITDA, 5 Yr. CAGR % | -16.02 | -5.09 | -10.82 | -3.36 | -2.76 | |||||
EBITA, 5 Yr. CAGR % | -34.72 | -8.57 | -18.92 | -2.61 | 0.01 | |||||
EBIT, 5 Yr. CAGR % | -35.11 | -8.53 | -19.01 | -2.62 | 0.04 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -43.13 | -9.99 | -26.1 | -7.17 | -2.93 | |||||
Net Income, 5 Yr. CAGR % | -43.13 | -9.99 | -26.1 | -7.11 | -2.87 | |||||
Normalized Net Income, 5 Yr. CAGR % | -40.38 | -9.87 | -21.47 | -3.55 | -2.27 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -43.13 | -9.99 | -26.06 | -6.81 | -2.35 | |||||
Accounts Receivable, 5 Yr. CAGR % | -5.16 | -8.92 | -10.66 | -12.21 | -0.86 | |||||
Inventory, 5 Yr. CAGR % | 9 | 3.29 | 4.74 | -0.19 | 1.3 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 22.57 | 15.54 | 15.75 | 13.95 | 16.09 | |||||
Total Assets, 5 Yr. CAGR % | 15.24 | 12.77 | 11.31 | 8.82 | 8.39 | |||||
Tangible Book Value, 5 Yr. CAGR % | -1 | -0.24 | -3.06 | -4.62 | -4.69 | |||||
Common Equity, 5 Yr. CAGR % | -1.21 | -0.4 | -3.2 | -4.09 | -4.16 | |||||
Cash From Operations, 5 Yr. CAGR % | 1.48 | 13.42 | 2.54 | 9.78 | 1.84 | |||||
Capital Expenditures, 5 Yr. CAGR % | -19.39 | -25.31 | -15.18 | -3.53 | 6.38 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 19.1 | 40.33 | 30.12 | 27.48 | -0.96 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 20.17 | 40.83 | 30.9 | 28.63 | 0.8 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | -7.79 | -7.79 | -7.79 | - |
- Stock Market
- Equities
- HM B Stock
- Financials Hennes & Mauritz AB
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















